Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concerns

A Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated prices. The NGO wants these health supplements to be overseen by drug regulators, not food safety authorities. This move aims to ensure better standards and fair pricing for consumers across India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lYkuRW7
via IFTTT

Read More

Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concerns

In India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic for gradual weight reduction. Healthcare professionals are urging the need for stringent regulations to prevent misuse and improper marketing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bomlCn8
via IFTTT

Read More

India medical tourism slips below pre-Covid peak amid geopolitics, visa delays and rising Asian competition

India's medical tourism is facing challenges. Arrivals have dropped significantly below pre-Covid levels. Geopolitical tensions and visa delays are impacting the sector. Competition from other Asian nations is also a factor. Industry leaders suggest focusing on high-tech, reliable healthcare delivery to attract international patients. Improvements in ties with Bangladesh could help reverse the trend.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cqGQXyS
via IFTTT

Read More

Poonawalla's clear shot at access for all via route social

Cyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccines have saved over 30 million lives worldwide. The institute's founding values of affordability, quality, and access continue to guide its global efforts. The Villoo Poonawalla Foundation also drives philanthropy in healthcare, education, and community development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zf6gNs4
via IFTTT

Read More

Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable care

Mankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and has expanded into chronic and specialty treatments. With over 75% of manufacturing in-house, Mankind Pharma emphasizes quality, affordability, and accessibility. They are investing in innovation and digital capabilities to meet growing healthcare needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gnfC5sd
via IFTTT

Read More

Alembic Pharma gets USFDA nod for generic cancer, arthritis injection

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used to treat multiple cancers and arthritis conditions. The approval covers key dosage formats and confirms therapeutic equivalence to the reference drug by Hospira, enabling Alembic to market the injectable in the US. Methotrexate is widely used for treating cancers such as leukemia, osteosarcoma and breast cancer, as well as conditions like rheumatoid arthritis and severe psoriasis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gCi15TF
via IFTTT

Read More

Eye on aspirational India, medical tourism, Max Healthcare steps up bed capacity expansion

Max Healthcare Institute Ltd is expanding capacity to 10,000 beds over the next 3–4 years, investing ₹4,000–5,000 crore to meet rising domestic demand and boost medical tourism.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tGoLmXP
via IFTTT

Read More